CRIS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 11:49):
Our systems believe the stock currently is undervalued by 0.12% compare to its pairs and should correct upwards.

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States...

Stats
Today's Volume	11 889
Average Volume	32 461
Market Cap	45.41M
EPS	$-2.05 ( Q1 \| 2024-05-07 )
Next earnings date	( $-1.700 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.890 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0370 (0.48%)

AADI -2.65%

ABCL 2.38%

ABCM 0.04%

ABEO -1.90%

ABIO -1.69%

ABOS 0.00%

ABSI 2.21%

ABUS -2.30%

ABVX -2.03%

ACAD -0.45%

ACER -17.95%

ACET -4.76%

ACGN 1.29%

ACHL -2.20%

ACHV -1.29%

ACIU -1.50%

ACLX 0.58%

ACRV -4.79%

ACST -3.58%

ACXP 1.38%

ADAG 4.64%

ADAP -4.25%

ADGI 0.87%

ADIL 0.54%

ADMA -2.54%

ADPT 0.30%

ADTX -3.47%

ADVM -3.40%

ADXN -1.60%

AEON -3.74%

AEZS -2.49%

AFMD -1.05%

AGEN -2.56%

AGIO -2.42%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -1.63%

AKRO -2.43%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -1.51%

ALEC -0.46%

ALGS -1.16%

ALKS 0.08%

ALLK -8.51%

ALLO -4.79%

ALLR -3.37%

ALNA 3.16%

ALNY 1.95%

ALPN 0.02%

ALPX 0.00%

ALRN 0.33%

ALT -9.58%

ALVR 2.59%

ALXN 0.00%

ALXO -11.19%

ALZN 1.97%

AMRN -0.73%

AMTI -3.13%

ANAB 1.51%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -1.12%

ANPC -3.15%

APGE -0.77%

APGN 8.48%

APGNW 30.65%

APLM -6.47%

APLS 1.11%

APLT -3.72%

APM -2.94%

APOP 0.38%

APRE 0.60%

APTO 6.30%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.40%

ARDS -14.23%

ARDX -0.17%

ARGX -1.09%

ARNA 0.00%

ARPO -0.90%

ARQT -1.04%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.60%

ARWR -1.67%

ASLN -5.07%

ASMB -8.31%

ASND -1.27%

ATAI -1.11%

ATHA 5.48%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 0.97%

ATRA -4.10%

ATXI 1.93%

ATXS -0.33%

AUPH -0.81%

AURA 1.91%

AUTL -1.58%

AVBP -4.23%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -4.17%

AVTX -1.25%

AVXL -2.84%

AXLA 0.00%

AXSM -1.28%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.57%

BCAB 4.58%

BCDA -2.23%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 1.48%

BCTX 8.16%

BCTXW -16.32%

BCYC 1.30%

BDRX -4.94%

BDTX -0.64%

BEAM 1.11%

BFRA -2.91%

BGNE -2.86%

BIOR -5.21%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.62%

BLU 0.03%

BLUE -0.19%

BMEA -11.14%

BMRN 0.58%

BNOX 4.61%

BNTC -0.42%

BNTX -1.57%

BOLD -8.47%

BOLT 0.72%

BPMC -0.90%

BPTH 1.42%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 31.34%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 1.46%

CADL -1.31%

CALA 0.00%

CALC -1.77%

CALT -1.14%

CAPR -2.80%

CARA 0.18%

CARM 11.79%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.22%

CCCC -5.21%

CCXI 0.00%

CDAK 0.00%

CDIO -2.20%

CDIOW 24.00%

CDMO -2.78%

CDMOP 0.04%

CDT -12.24%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.41%

CDXS 7.24%

CELC -3.73%

CELU -0.67%

CELUW 11.80%

CERC -1.68%

CERE -0.99%

CERO -3.40%

CEROW -22.75%

CFRX -27.95%

CGEM -2.13%

CGEN -3.31%

CGON -0.73%

CGTX -4.56%

CHMA -6.00%

CHRS 0.32%

CINC 0.00%

CING 0.26%

CINGW 34.95%

CKPT -2.42%

CLBS -16.75%

CLDX -1.96%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 8.55%

CLSD 0.43%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 2.42%

CMPI 0.00%

CMPX -7.48%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.04%

CNCE 0.00%

CNSP -35.56%

CNST 0.00%

CNTA -0.67%

CNTB 0.00%

CNTX -6.85%

COCP -2.00%

COEPW 32.45%

COGT -2.04%

CORT 2.37%

COYA -1.46%

CPRX -1.06%

CRBP -3.18%

CRBU -4.26%

CRDF -1.32%

CRGX 0.64%

CRIS -1.70%

CRNX -5.82%

CRSP 1.29%

CRTX 2.63%

CRVO -2.50%

CRVS 1.82%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -3.31%

CTNM -2.33%

CTXR 2.89%

CUE 4.83%

CVAC -2.26%

CVKD 0.10%

CWBR 2.80%

CYAD -12.96%

CYCC 8.18%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.85%

CYTO -2.70%

DARE 6.41%

DAWN 0.67%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.69%

DNLI -0.94%

DNTH -9.22%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -2.11%

DTIL 0.56%

DYAI 10.32%

EARS -1.77%

EDIT -2.52%

EDSA 3.19%

EFTR 4.25%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 8.02%

ELEV -5.81%

ELOX 7.69%

ELTX -0.88%

ELVN -4.35%

ELYM 2.30%

ENGN -3.45%

ENGNW 0.00%

ENLV 2.54%

ENOB 1.79%

ENSC 5.16%

ENTA -0.57%

ENTO -2.42%

ENTX 2.08%

ENVB 1.42%

EPIX -0.31%

EPRX -2.97%

EPZM 0.00%

EQ 0.32%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON 2.13%

ETTX 0.00%

EVAX -2.14%

EVGN 3.97%

EVLO 0.00%

EWTX 0.06%

EXAI -0.95%

EXEL -0.20%

EYEG -0.69%

EYEN 0.95%

EYPT 0.97%

FATE -7.39%

FBIO 0.89%

FBIOP 0.92%

FBLG -15.40%

FBRX -0.04%

FDMT -3.80%

FENC -1.29%

FGEN -4.70%

FHTX 2.67%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.23%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.13%

FULC -3.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.28%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.09%

GHRS -2.13%

GLMD -5.09%

GLPG -2.26%

GLSI 1.69%

GLTO -0.57%

GLUE -2.51%

GLYC -10.18%

GMAB -0.62%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -3.91%

GNLX 1.33%

GNPX 0.98%

GNTA 3.94%

GOSS -11.71%

GOVX 5.00%

GOVXW -49.04%

GPCR -6.93%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.32%

GRTX 2.57%

GTHX 0.91%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.21%

HALO -1.17%

HARP 0.09%

HCWB -3.75%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX 0.08%

HOOK 0.00%

HOTH -2.70%

HOWL -1.72%

HRMY 0.83%

HRTX 4.26%

HSTO 0.00%

HUMA 0.60%

HUMAW -0.01%

IBRX -3.51%

ICCC 0.22%

ICPT 0.21%

ICU 18.84%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.58%

IFRX -1.80%

IGMS -0.44%

IKNA 1.19%

IKT 1.42%

IMAB 0.00%

IMCR -2.99%

IMGN 0.02%

IMGO 0.00%

IMMP 6.08%

IMMX -7.33%

IMNM -1.52%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.42%

IMTX -1.67%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.70%

INAB -0.01%

INBX 0.93%

INCY -0.90%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 1.92%

INMB 1.95%

INO -2.47%

INSM -1.13%

INTS -2.75%

INVA 0.50%

INZY 1.03%

IOBT -11.02%

IONS 0.21%

IOVA -1.95%

IPA 0.00%

IPHA 5.58%

IPSC -1.95%

IRON -2.68%

ISEE 0.38%

ITOS -1.90%

ITRM 1.67%

IVA 6.96%

IVVD -2.47%

JAGX 1.84%

JANX -3.54%

JAZZ -0.66%

JNCE 0.00%

JSPR -5.96%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -1.52%

KDNY 0.22%

KMPH -0.34%

KNSA -2.64%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -2.29%

KRBP -10.00%

KRON 1.05%

KROS -1.20%

KRRO -8.20%

KRTX 0.03%

KRYS -1.01%

KTRA 15.68%

KTTA 8.16%

KTTAW 0.92%

KURA -1.12%

KYMR -2.34%

KYTX -3.26%

KZIA 2.65%

KZR -0.21%

LABP 0.57%

LBPH -2.21%

LBPS 0.00%

LBPSW 14.81%

LEGN 2.18%

LENZ -3.30%

LEXX 0.76%

LEXXW -14.63%

LGND -1.33%

LGNDV 0.00%

LGVN -10.08%

LIAN -8.28%

LIFE 2.70%

LIPO -11.13%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.65%

LPCN -2.94%

LPTX -1.10%

LQDA -0.57%

LRMR -2.63%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -4.21%

LXRX -1.76%

LYEL -33.33%

LYRA 1.32%

MACK 0.10%

MBIO -11.82%

MBRX -2.57%

MCRB 2.61%

MDGL -3.04%

MDNA -13.16%

MDWD 0.03%

MDXG -2.50%

MEIP -0.13%

MESO -2.08%

MGNX -3.03%

MGTA -7.74%

MGTX -3.33%

MGX -4.83%

MIRM -1.84%

MIRO 0.59%

MIST 0.77%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -1.06%

MLYS -5.88%

MNKD -1.05%

MNMD 0.50%

MNOV 2.11%

MNPR -5.01%

MOLN 1.79%

MOR 1.20%

MORF -2.60%

MREO -3.57%

MRKR 2.68%

MRNA -5.05%

MRNS -4.04%

MRSN -1.67%

MRTX -0.17%

MRUS 0.32%

MRVI -1.97%

MTCR -1.29%

MTEM 4.95%

MTP -18.50%

MURA -0.93%

MYMD 5.41%

NAMS 1.88%

NAMSW 0.43%

NAUT 1.78%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.82%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.25%

NKGN 9.24%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.24%

NLSP 8.44%

NLSPW 26.67%

NMRA -1.49%

NMTR -42.97%

NOVN -24.84%

NRBO 11.00%

NRIX -0.50%

NRSN -5.12%

NRSNW 0.00%

NRXP -5.20%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -5.38%

NTRBW -31.07%

NUVL -1.05%

NVAX -2.14%

NVCT 4.51%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.26%

OABIW -10.06%

OBIO -4.67%

OBSV 0.00%

OCEA -0.70%

OCGN 3.81%

OCS -1.00%

OCUL -1.30%

OCUP 1.31%

ODT -4.27%

OKYO 1.51%

OLMA -5.88%

OMER -0.51%

OMGA 5.42%

ONCO 4.96%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY 0.00%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 2.06%

ORGS 0.65%

ORIC -2.97%

ORMP 21.43%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI 2.58%

PASG -1.30%

PBLA -7.50%

PBM -8.21%

PBYI 1.35%

PCSA 0.00%

PCVX 0.04%

PDSB -3.64%

PEPG 1.85%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.16%

PHIO -0.83%

PHIOW 36.47%

PHVS -6.81%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.92%

PLUR 5.78%

PMN 0.72%

PMVP 0.00%

PNT 0.16%

PPBT -6.84%

PRAX 1.51%

PRDS 0.93%

PRLD -3.17%

PROG -3.47%

PROK -0.45%

PRQR 0.00%

PRTA -2.07%

PRTC 0.49%

PRTG -0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -8.54%

PSTX -0.39%

PTCT -0.54%

PTE -0.82%

PTGX -1.14%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.47%

QLGN -8.22%

QNCX 5.70%

QNRX 0.37%

QSI -11.86%

QSIAW -3.13%

QTTB -1.42%

QURE -0.67%

RAIN -1.63%

RANI 6.42%

RAPT -2.89%

RARE 1.51%

RCKT -7.67%

REGN -0.26%

RENB -3.42%

REPL -2.61%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -5.37%

RGNX -5.19%

RIGL -3.29%

RLAY -3.71%

RLMD 0.33%

RLYB -0.67%

RNA 0.21%

RNAC -5.94%

RNAZ -0.63%

RNXT 0.01%

ROIV -1.76%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.30%

RPTX -2.79%

RUBY 2.70%

RVLP -32.05%

RVMD -0.86%

RVMDW -30.00%

RVNC 2.34%

RVPH -1.19%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.04%

RYTM -5.63%

RYZB 0.02%

RZLT 0.78%

SABS -1.37%

SABSW -11.81%

SAGE 1.74%

SANA -3.23%

SAVA -0.60%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 2.40%

SCPS 0.00%

SEEL -4.74%

SEER 1.18%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 0.90%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -7.06%

SLGL 2.97%

SLN -4.40%

SLNO -4.08%

SLRX 6.07%

SLS -2.14%

SMMT -2.43%

SNDX 1.51%

SNGX -4.91%

SNPX -3.84%

SONN -1.08%

SPPI -0.49%

SPRB 0.91%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -1.11%

SRRA 0.00%

SRRK -1.73%

SRZN -2.45%

STAB 0.00%

STOK -4.16%

STRO -2.84%

STSA 0.00%

STTK -0.84%

SURF -0.93%

SVRA -4.88%

SWTX 0.52%

SYBX -1.29%

SYRS -1.03%

TALS -0.73%

TARA -6.19%

TARS -0.02%

TBPH 0.48%

TCBP 2.47%

TCDA 0.00%

TCON 2.46%

TCRR 0.00%

TCRT 1.59%

TCRX 1.45%

TECH -0.11%

TENX 1.91%

TERN -7.99%

TFFP -5.33%

TGTX -2.97%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -2.59%

TNGX -2.59%

TNXP -6.19%

TNYA -4.36%

TPST 2.92%

TRDA -4.64%

TRVI 2.30%

TRVN 2.97%

TSHA -23.73%

TSVT -2.93%

TTNP -7.66%

TVTX 1.13%

TYRA -7.13%

UBX -2.13%

UNCY -4.04%

URGN -1.27%

UTHR -0.26%

VACC 11.36%

VALN -2.89%

VAXX 80.94%

VBIV 0.78%

VBLT -8.77%

VCEL -0.23%

VCNX 10.35%

VCYT -0.70%

VERA -3.35%

VERU -0.55%

VERV -2.68%

VIGL 6.32%

VINC 2.96%

VIR 0.98%

VIRI -1.61%

VIRX 2.40%

VKTX -1.37%

VLON -13.04%

VNDA -2.44%

VOR -2.02%

VRCA 0.14%

VRDN -4.15%

VRNA -1.26%

VRPX 0.38%

VRTX 0.38%

VSTM -0.85%

VTGN -1.05%

VTVT -2.97%

VTYX -1.46%

VXRT -3.01%

VYGR -0.51%

VYNE -4.62%

VYNT 7.78%

WINT -3.24%

WVE -4.40%

XBIO 0.93%

XBIT 1.04%

XCUR 3.58%

XENE -2.73%

XERS 2.14%

XFOR 2.52%

XLO 4.54%

XLRN 0.00%

XNCR 0.67%

XOMA -2.94%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.63%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.89%

ZNTL -0.72%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-05-21	Duvall Diantha	Buy	39 000	Employee stock option (right to buy)
2024-05-21	Dentzer James E	Buy	100 000	Employee stock option (right to buy)
2024-05-21	Zung Jonathan B.	Buy	40 700	Employee stock option (right to buy)
2024-05-21	Kaitin Kenneth I	Buy	4 250	Non Qualified Stock Option
2024-05-21	Rubin Marc	Buy	4 250	Non Qualified Stock Option

INSIDER POWER
92.59
Last 97 transactions
Buy: 15 058 067 \| Sell: 988 251

Correlation (AI algo v.1.1b): Undervalued: 0.12% $7.71 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Curis Inc Correlation

10 Most Positive Correlations
OZEM	1
NIVF	0.914
IRON	0.886
FTREX	0.874
LDTC	0.874
PMEC	0.872
GDC	0.867
MVSTW	0.866
OPTX	0.861
EH	0.855

10 Most Negative Correlations
GLBZ	-0.891
AILEW	-0.878
MTEN	-0.866
OPTZ	-0.861
BOTT	-0.857
GECCI	-0.853
MNDO	-0.841
CCSB	-0.836
BRZE	-0.836
WRAP	-0.836

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Curis Inc Financials

Annual	2023
Revenue:	$10.02M
Gross Profit:	$9.81M (97.88 %)
EPS:	$-8.96

FY	2023
Revenue:	$10.02M
Gross Profit:	$9.81M (97.88 %)
EPS:	$-8.96

FY	2022
Revenue:	$10.16M
Gross Profit:	$9.91M (97.47 %)
EPS:	$-12.92

FY	2021
Revenue:	$10.65M
Gross Profit:	$10.12M (94.99 %)
EPS:	$-0.500

Financial Reports:

No articles found.

Curis Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Curis Inc

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize the V-domain Ig suppressor of T cell activation. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with MYC-altered diffuse large B-cell lymphoma; CA-170, an oral small molecule drug candidate for treating patients with advanced solid tumors and lymphomas; and CA-327, a pre-investigational new drug stage oncology drug candidate. It has collaboration agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc. for the development and commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway inhibitor for the treatment of advanced basal cell carcinoma; and with Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology. Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts.